ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-01-700-7178, 6505017007178
IBREXAFUNGERP TABLETS

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 017007178
Codification Country
United States
Item Name Code
INC 77777
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-01-700-7178
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-01-700-7178


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-01-700-7178

National Stock Number (NSN) 6505-01-700-7178, or NIIN 017007178, (ibrexafungerp tablets) was assigned April 11, 2022 in the Federal Logistics Information System (FLIS). This NSN does not replace any other NSNs.

There are 3 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by one supplier. Today, one supplier is listed as an Active supplier for this NSN. Of the active suppliers, only one supplier is deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

There has been a small amount of demand for this national stock number. The demand for this NSN originated from less than 5 countries.

This NSN is assigned to Item Name Code (INC) 77777. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505017007178 does not contain precious metals.

This information was last updated on .


Technical Characteristics

PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) IBREXAFUNGERP TABLETS; 150 MG PER TABLET; 4S
SPECIAL FEATURES
(FEAT) INDICATED FOR THE TREATMENT OF ADULT AND POST-MENARCHAL PEDIATRIC FEMALES WITH VULVOVAGINAL CANDIDIASIS (VVC); ARE PURPLE, OVAL, BICONVEX SHAPED TABLETS DEBOSSED WITH 150 ON ONE SIDE AND SCYX ON THE OTHER SIDE; EACH TABLET CONTAINS 150 MG IBREXAFUNGERP (EQUIVALENT TO 189.5 MG OF IBREXAFUNGERP CITRATE); TABLETS ARE PACKAGED IN POLYVINYL/POLYVINYLIDENE CHLORIDE CHILD-RESISTANT BLISTER PACKS, FOUR (4) TABLETS PER PACK; STORE TABLETS AT 20 C TO 25 C (68 F TO 77 F). BRIEF EXPOSURE TO 15 C TO 30 C (59 F TO 86 F) PERMITTED (SEE USP CONTROLLED ROOM TEMPERATURE); SHELF LIFE OF 36 MONTHS.

Manufacturer Part Numbers


Related Inventory



 
Top